These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

464 related items for PubMed ID: 10234806

  • 1. Multiple differentiation pathways of rat mammary stromal cells in vitro: acquisition of a fibroblast, adipocyte or endothelial phenotype is dependent on hormonal and extracellular matrix stimulation.
    Zangani D, Darcy KM, Masso-Welch PA, Bellamy ES, Desole MS, Ip MM.
    Differentiation; 1999 Jan; 64(2):91-101. PubMed ID: 10234806
    [Abstract] [Full Text] [Related]

  • 2. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction.
    Meng L, Zhou J, Sasano H, Suzuki T, Zeitoun KM, Bulun SE.
    Cancer Res; 2001 Mar 01; 61(5):2250-5. PubMed ID: 11280794
    [Abstract] [Full Text] [Related]

  • 3. Interaction with endothelial cells is a prerequisite for branching ductal-alveolar morphogenesis and hyperplasia of preneoplastic human breast epithelial cells: regulation by estrogen.
    Shekhar MP, Werdell J, Tait L.
    Cancer Res; 2000 Jan 15; 60(2):439-49. PubMed ID: 10667599
    [Abstract] [Full Text] [Related]

  • 4. Transcriptional regulation of vascular endothelial growth factor expression in epithelial and stromal cells during mouse mammary gland development.
    Hovey RC, Goldhar AS, Baffi J, Vonderhaar BK.
    Mol Endocrinol; 2001 May 15; 15(5):819-31. PubMed ID: 11328861
    [Abstract] [Full Text] [Related]

  • 5. Adenovirus-mediated wild-type p53 overexpression inhibits endothelial cell differentiation in vitro and angiogenesis in vivo.
    Riccioni T, Cirielli C, Wang X, Passaniti A, Capogrossi MC.
    Gene Ther; 1998 Jun 15; 5(6):747-54. PubMed ID: 9747454
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of angiogenesis by the cancer chemopreventive agent conjugated linoleic acid.
    Masso-Welch PA, Zangani D, Ip C, Vaughan MM, Shoemaker S, Ramirez RA, Ip MM.
    Cancer Res; 2002 Aug 01; 62(15):4383-9. PubMed ID: 12154044
    [Abstract] [Full Text] [Related]

  • 7. Angiogenesis by fibroblast growth factor 4 is mediated through an autocrine up-regulation of vascular endothelial growth factor expression.
    Deroanne CF, Hajitou A, Calberg-Bacq CM, Nusgens BV, Lapière CM.
    Cancer Res; 1997 Dec 15; 57(24):5590-7. PubMed ID: 9407972
    [Abstract] [Full Text] [Related]

  • 8. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels.
    Goto F, Goto K, Weindel K, Folkman J.
    Lab Invest; 1993 Nov 15; 69(5):508-17. PubMed ID: 8246443
    [Abstract] [Full Text] [Related]

  • 9. The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects.
    Béliveau R, Gingras D, Kruger EA, Lamy S, Sirois P, Simard B, Sirois MG, Tranqui L, Baffert F, Beaulieu E, Dimitriadou V, Pépin MC, Courjal F, Ricard I, Poyet P, Falardeau P, Figg WD, Dupont E.
    Clin Cancer Res; 2002 Apr 15; 8(4):1242-50. PubMed ID: 11948139
    [Abstract] [Full Text] [Related]

  • 10. The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-gamma pathway and partially induces mitotic signals in NIH3T3 fibroblasts.
    Takahashi T, Shibuya M.
    Oncogene; 1997 May 01; 14(17):2079-89. PubMed ID: 9160888
    [Abstract] [Full Text] [Related]

  • 11. The coronary endothelium: a target for vascular endothelial growth factor. Human coronary artery endothelial cells express functional receptors for vascular endothelial growth factor in vitro and in vivo.
    Kranz A, Mayr U, Frank H, Waltenberger J.
    Lab Invest; 1999 Aug 01; 79(8):985-91. PubMed ID: 10462036
    [Abstract] [Full Text] [Related]

  • 12. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.
    Samaniego F, Markham PD, Gendelman R, Watanabe Y, Kao V, Kowalski K, Sonnabend JA, Pintus A, Gallo RC, Ensoli B.
    Am J Pathol; 1998 Jun 01; 152(6):1433-43. PubMed ID: 9626048
    [Abstract] [Full Text] [Related]

  • 13. A simple immunomagnetic protocol for the selective isolation and long-term culture of human dermal microvascular endothelial cells.
    Richard L, Velasco P, Detmar M.
    Exp Cell Res; 1998 Apr 10; 240(1):1-6. PubMed ID: 9570915
    [Abstract] [Full Text] [Related]

  • 14. Vascular endothelial growth factor confers a growth advantage in vitro and in vivo to stromal cells cultured from neonatal hemangiomas.
    Berard M, Sordello S, Ortega N, Carrier JL, Peyri N, Wassef M, Bertrand N, Enjolras O, Drouet L, Plouet J.
    Am J Pathol; 1997 Apr 10; 150(4):1315-26. PubMed ID: 9094988
    [Abstract] [Full Text] [Related]

  • 15. Vascular endothelial growth factor-toxin conjugate specifically inhibits KDR/flk-1-positive endothelial cell proliferation in vitro and angiogenesis in vivo.
    Ramakrishnan S, Olson TA, Bautch VL, Mohanraj D.
    Cancer Res; 1996 Mar 15; 56(6):1324-30. PubMed ID: 8640821
    [Abstract] [Full Text] [Related]

  • 16. Regulation of VEGF and VEGF receptor expression in the rodent mammary gland during pregnancy, lactation, and involution.
    Pepper MS, Baetens D, Mandriota SJ, Di Sanza C, Oikemus S, Lane TF, Soriano JV, Montesano R, Iruela-Arispe ML.
    Dev Dyn; 2000 Jul 15; 218(3):507-24. PubMed ID: 10878616
    [Abstract] [Full Text] [Related]

  • 17. Expression and endocytosis of VEGF and its receptors in human colonic vascular endothelial cells.
    Wang D, Lehman RE, Donner DB, Matli MR, Warren RS, Welton ML.
    Am J Physiol Gastrointest Liver Physiol; 2002 Jun 15; 282(6):G1088-96. PubMed ID: 12016135
    [Abstract] [Full Text] [Related]

  • 18. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF.
    Seetharam L, Gotoh N, Maru Y, Neufeld G, Yamaguchi S, Shibuya M.
    Oncogene; 1995 Jan 05; 10(1):135-47. PubMed ID: 7824266
    [Abstract] [Full Text] [Related]

  • 19. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
    Yano S, Herbst RS, Shinohara H, Knighton B, Bucana CD, Killion JJ, Wood J, Fidler IJ.
    Clin Cancer Res; 2000 Mar 05; 6(3):957-65. PubMed ID: 10741721
    [Abstract] [Full Text] [Related]

  • 20. The angiogenesis inhibitor SU5416 has long-lasting effects on vascular endothelial growth factor receptor phosphorylation and function.
    Mendel DB, Schreck RE, West DC, Li G, Strawn LM, Tanciongco SS, Vasile S, Shawver LK, Cherrington JM.
    Clin Cancer Res; 2000 Dec 05; 6(12):4848-58. PubMed ID: 11156244
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.